Quick Answer: Compounded semaglutide costs 70-90% less than brand Wegovy ($100-400/month vs $1,000-1,300/month), but is NOT FDA-approved, has variable quality by pharmacy, and the FDA ended the semaglutide shortage in February 2025—which has major implications for compounders. This requires careful consideration of risk vs cost.
Safety Disclaimer: Compounded medications carry real safety risks including contamination, inconsistent dosing, and lack of clinical evidence. Any decision to use compounded semaglutide must be made with a licensed healthcare provider who understands your health profile. Verify pharmacy credentials and understand the risks.
What Is Compounded Semaglutide?
Semaglutide is the active ingredient in brand medications like Wegovy (weight loss) and Ozempic (diabetes). Brand-name semaglutide is manufactured by Novo Nordisk under strict FDA oversight, tested for purity, and approved for specific uses.
Compounded semaglutide is made by specialized pharmacies using pharmaceutical ingredients they combine themselves. It is NOT manufactured by Novo Nordisk and is NOT FDA-approved in the same way brand medications are.
Two Types of Compounding
- 503B Pharmacies (Outsourcing): Larger, registered with FDA, can compound without patient-specific prescriptions. Some scale semaglutide compounding.
- 503A Pharmacies (Traditional): Smaller local pharmacies that compound only with valid prescriptions. Require individual patient prescriptions.
Both operate under less oversight than FDA-approved manufacturers. The FDA historically allows compounding during documented shortages—which is why the February 2025 shortage ending is so significant.
Key Differences: Compounded vs Brand
| Factor | Brand-Name (Wegovy) | Compounded |
|---|---|---|
| FDA Approval | FDA-approved; clinically tested | NOT FDA-approved; different oversight |
| Manufacturer | Novo Nordisk (pharmaceutical company) | Local/regional compounding pharmacy |
| Quality Testing | Rigorous batch testing for purity, potency, sterility | Varies by pharmacy; no standardized requirement |
| Dosing Accuracy | Pre-filled pens with exact, verified doses | May vary slightly between batches |
| Clinical Evidence | Extensive clinical trials proving safety and efficacy | No clinical trials on compounded versions |
| Cost (Monthly) | $1,000-1,300 (cash); $250-500 (insurance) | $100-400 plus telehealth fees ($150-300) |
The FDA Shortage Ruling: What Changed February 2025?
In February 2025, the FDA officially declared that the semaglutide shortage had ended. This is critical because the FDA permits compounding of brand-name drugs primarily during documented shortages.
With the shortage officially over, the FDA's legal justification for allowing semaglutide compounding no longer applies. This means:
- Compounding pharmacies' legal ability to compound semaglutide is now questionable
- The FDA could take enforcement action against compounders continuing without a documented shortage
- Some pharmacies may discontinue semaglutide compounding
- Availability may decrease significantly over the next 6-12 months
Note: The FDA has not issued a blanket prohibition, but the legal landscape has shifted. Patients relying on compounded semaglutide should be prepared for potential unavailability.
Safety Concerns: What You Need to Know
1. Contamination Risk
Compounding pharmacies prepare medications in-house, introducing contamination risks absent in pharmaceutical manufacturing. Contaminated compounded GLP-1 products have been reported, including bacterial and mold contamination. While rare, these incidents have harmed patients.
2. Dosing Accuracy Variability
Brand Wegovy comes in pre-filled pens with exact, verified doses. Compounded semaglutide may vary between batches. A dose meant to be 0.5 mg might actually be 0.47 mg or 0.53 mg—small differences affecting efficacy and safety over time.
3. No Clinical Trials on Compounded Versions
All safety and efficacy data for semaglutide comes from clinical trials of brand-name Wegovy and Ozempic. There are NO clinical trials of compounded semaglutide. While the active ingredient is the same, the lack of clinical evidence on the compounded product is a real safety gap.
4. Reported Adverse Events
The FDA has received reports of adverse events from compounded GLP-1 products, including allergic reactions, injection site issues, and unexplained efficacy fluctuations. While causation is hard to establish, these suggest compounded products may not be equivalent to brand versions.
5. Limited Pharmacovigilance
Brand manufacturers must monitor and report adverse events. Compounding pharmacies have no such systematic requirement. Safety issues with compounded semaglutide may go unreported and untracked.
6. Ingredient Sourcing Questions
Compounding pharmacies source semaglutide from pharmaceutical suppliers, but the supply chain for compounding ingredients is less transparent than for FDA-approved drugs. Origin of compounded semaglutide is often unclear.
Cost Comparison: The Real Numbers
Brand-Name Wegovy
- Cash price: $1,000-1,300/month (varies by dose)
- With insurance: Often $250-500/month with copay (if covered)
- With patient assistance programs: Some programs offer $99-199/month for qualifying patients
Compounded Semaglutide
- Typical cost: $100-400/month (wide range by pharmacy and dose)
- Insurance: Rarely covered; almost always out-of-pocket
- Plus telehealth fee: Many compounding pharmacies pair with telehealth providers ($150-300/month for consultation)
Total Cost (3 Months)
| Option | Pharmacy Cost | Telehealth Cost | Total |
|---|---|---|---|
| Brand Wegovy (cash) | $3,000-3,900 | $0 (included) | $3,000-3,900 |
| Brand Wegovy (insurance) | $750-1,500 | $0 | $750-1,500 |
| Compounded | $300-1,200 | $450-900 | $750-2,100 |
Important: The cost advantage of compounded options is real but can be offset by telehealth fees. If quality issues force you to switch providers or experience ineffectiveness, apparent cost savings disappear.
Frequently Asked Questions
Is compounded semaglutide FDA-approved?
No. Compounded semaglutide is NOT FDA-approved. The FDA approves brand-name medications like Wegovy, made by pharmaceutical companies under strict oversight. Compounded medications made by pharmacies fall under a different regulatory category. The FDA permits compounding under certain conditions (like shortages), but the products themselves are not FDA-approved.
Is compounded semaglutide safe?
Compounded semaglutide carries real safety risks. Quality varies by pharmacy, there are no clinical trials, and contamination cases have been reported. It's less safe than brand alternatives, though many patients use it without serious adverse events. Safety depends heavily on the pharmacy's standards and your provider's oversight.
How much can I save with compounded semaglutide?
Compounded semaglutide typically costs $100-400/month vs $1,000-1,300/month for brand Wegovy—a 70-90% reduction. However, add telehealth fees ($150-300/month) and savings shrink to 30-60% compared to brand with telehealth. Compare total cost, not just pharmacy cost.
What does the February 2025 FDA shortage ruling mean for me?
The shortage ending removes the FDA's legal justification for allowing semaglutide compounding. Over the next 6-12 months, availability of compounded semaglutide may decrease as the FDA clarifies enforcement and pharmacies reassess. If considering compounded options, be prepared for potential unavailability.
Can I verify a compounding pharmacy's quality?
Look for PCAB (Pharmacy Compounding Accreditation Board) accreditation, contact your state pharmacy board, and ask about testing protocols for sterility, potency, and purity. However, accreditation doesn't guarantee safety for semaglutide specifically. Request a certificate of analysis for your specific dose.
Which telehealth programs offer compounded vs brand semaglutide?
Hims has historically offered compounded semaglutide at lower cost; they're transitioning as brand availability improves. Ro, Calibrate, and Found primarily offer brand-name medications. Offerings change frequently—always ask your provider directly before enrolling.
The Bottom Line
Compounded semaglutide is significantly cheaper than brand Wegovy, but comes with meaningful safety trade-offs. Here's how to think about your options:
Choose Brand Wegovy if:
- You have insurance coverage (even with high copay)
- You qualify for patient assistance programs
- Safety and clinical evidence are your top priority
- You want the most predictable, consistent dosing
Consider Compounded Semaglutide only if:
- Cost is a genuine barrier and you've exhausted other options
- You use a verified, accredited pharmacy
- You have a provider actively monitoring your response and safety
- You understand and accept the safety risks
- You're prepared for potential unavailability post-shortage ruling
Explore These Alternatives First:
- Wegovy cost reduction strategies (patient assistance, GoodRx, state programs)
- Telehealth programs with insurance optimization
- Tirzepatide (newer, sometimes cheaper than semaglutide)
- State and local patient assistance programs
GLP-1 therapy is a significant investment. Ensure your choice reflects both your budget constraints and risk tolerance for safety.
Final Disclaimer
This article is for educational purposes and does not constitute medical advice. The decision to use compounded semaglutide should be made with a licensed healthcare provider who understands your medical history and risk factors. The FDA and healthcare providers continue to evaluate compounded semaglutide safety and legality. Information reflects the regulatory landscape as of March 2026 and may change. Always verify current information with your provider and pharmacy before making treatment decisions.